Extracorporeal photochemotherapy induces bona fide immunogenic cell death
2019 · Cell Death and Disease · 81 citations
https://doi.org/10.1038/s41419-019-1819-3
Yale University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
2.0K
Citations
20
h-index
27
i10-index
Douglas Hanlon is an academic researcher from Yale University. The author has contributed to research in topics: Immunotherapy and Immune Responses & CAR-T cell therapy research & Nanoplatforms for cancer theranostics. The author has an h-index of 20, co-authored 59 publications.
ORCID: 0000-0003-4386-7491Click to start Chat